B

Beijing Succeeder Technology Inc
SSE:688338

Watchlist Manager
Beijing Succeeder Technology Inc
SSE:688338
Watchlist
Price: 29.11 CNY -0.31%
Market Cap: ¥3.1B

Operating Margin

31.1%
Current
Declining
by 4.7%
vs 3-y average of 35.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
31.1%
=
Operating Income
¥88.9m
/
Revenue
¥285.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
31.1%
=
Operating Income
¥88.9m
/
Revenue
¥285.8m

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Beijing Succeeder Technology Inc
SSE:688338
3.1B CNY
Loading...
JP
Hoya Corp
TSE:7741
8.7T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.6B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.4B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
122B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.6B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
KR
HLB Inc
KOSDAQ:028300
8.6T KRW
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.9B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF
Loading...

Market Distribution

Higher than 93% of companies in China
Percentile
93rd
Based on 8 544 companies
93rd percentile
31.1%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Beijing Succeeder Technology Inc
Glance View

Market Cap
3.1B CNY
Industry
Health Care

Beijing Succeeder Technology, Inc. engages in research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company is headquartered in Beijing, Beijing and currently employs 266 full-time employees. The company went IPO on 2020-08-06. The firm provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The firm operates its businesses within the domestic market and to overseas markets.

Intrinsic Value
22.63 CNY
Overvaluation 22%
Intrinsic Value
Price
B
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
31.1%
=
Operating Income
¥88.9m
/
Revenue
¥285.8m
What is Beijing Succeeder Technology Inc's current Operating Margin?

The current Operating Margin for Beijing Succeeder Technology Inc is 31.1%, which is below its 3-year median of 35.8%.

How has Operating Margin changed over time?

Over the last 3 years, Beijing Succeeder Technology Inc’s Operating Margin has decreased from 35.1% to 31.1%. During this period, it reached a low of 31.1% on Jul 30, 2025 and a high of 38% on Sep 30, 2023.

Back to Top